# FDA Inspection 1180329 - WraSer Pharmaceuticals, LLC - September 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/wraser-pharmaceuticals-llc/761e3f01-2610-44a6-9f73-c98ef4e45bf7
Source feed: FDA_Inspections

> FDA Inspection 1180329 for WraSer Pharmaceuticals, LLC on September 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180329
- Company Name: WraSer Pharmaceuticals, LLC
- Inspection Date: 2022-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 717247 - 2011-03-25](https://www.keypedia.com/records/fda_inspections/wraser-pharmaceuticals-llc/9bf0a361-911c-41aa-8923-47134d7389a5)

Company: https://www.keypedia.com/companies/wraser-pharmaceuticals-llc/694b9d0c-35a9-4387-af64-c6d3a693e522

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c